Nocturia: Current Levels of Evidence and Recommendations From the International Consultation on Male Lower Urinary Tract Symptoms.

[1]  M. Ebell,et al.  A systematic review of the efficacy and safety of desmopressin for nocturia in adults. , 2014, The Journal of urology.

[2]  P. Abrams,et al.  Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. , 2014, European urology.

[3]  C. Nardo,et al.  OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. , 2013, European urology.

[4]  Ja-Hong Kim.  Nocturia: Causes, Consequences and Clinical Approaches , 2013 .

[5]  M. Speakman,et al.  Male Lower Urinary Tract Symptoms , 2013 .

[6]  A. Heidarzadeh,et al.  Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates , 2013, World Journal of Urology.

[7]  J. Nørgaard,et al.  Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double‐blind, placebo‐controlled trial , 2012, Neurourology and urodynamics.

[8]  Xiaoxia Peng,et al.  Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials , 2012, International Urology and Nephrology.

[9]  A. Markland,et al.  Behavioral Versus Drug Treatment for Overactive Bladder in Men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial , 2011, Journal of the American Geriatrics Society.

[10]  J. Bosch,et al.  Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen study. , 2011, The Journal of urology.

[11]  C. Roehrborn,et al.  Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. , 2011, JAMA.

[12]  Choal Hee Park,et al.  Long-Term Effect of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia , 2011, Korean journal of urology.

[13]  A. Papatsoris,et al.  Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia , 2011, International journal of urology : official journal of the Japanese Urological Association.

[14]  M. Drake,et al.  Nocturia as a manifestation of systemic disease , 2011, BJU international.

[15]  T. Tammela,et al.  Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. , 2011, European urology.

[16]  O. Ogawa,et al.  Efficacy of nondrug lifestyle measures for the treatment of nocturia. , 2010, The Journal of urology.

[17]  A. Krystal,et al.  Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study. , 2010, The Journal of urology.

[18]  J. J. de la Rosette,et al.  The role of nocturia in the quality of life of men with lower urinary tract symptoms , 2010, BJU international.

[19]  T. Tammela,et al.  Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. , 2010, European urology.

[20]  P. Abrams,et al.  International consultation on urological diseases: Evidence‐based medicine overview of the main steps for developing and grading guideline recommendations , 2010, Neurourology and urodynamics.

[21]  S. Madersbacher,et al.  Nocturia is an age‐independent risk factor for hip‐fractures in men , 2009, Neurourology and urodynamics.

[22]  T. Tammela,et al.  A Systematic Evaluation of Factors Associated With Nocturia—The Population-based FINNO Study , 2009, American journal of epidemiology.

[23]  J. Wyndaele,et al.  Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study , 2009, International journal of clinical practice.

[24]  Katsunori Yoshida,et al.  The relationship between nocturnal polyuria and the distribution of body fluid: assessment by bioelectric impedance analysis. , 2009, The Journal of urology.

[25]  M. Kaye.  Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics. , 2008, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[26]  S. Falahatkar,et al.  Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. , 2008, Urology.

[27]  T. Tammela,et al.  Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. , 2008, American journal of obstetrics and gynecology.

[28]  C. Roehrborn,et al.  The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. , 2007, The Journal of urology.

[29]  A. Tubaro,et al.  Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. , 2007, European urology.

[30]  S. Kaplan,et al.  Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. , 2007, European urology.

[31]  J. Mckinlay,et al.  The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. , 2007, The Journal of urology.

[32]  C. Roehrborn,et al.  Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. , 2006, JAMA.

[33]  M. Choo,et al.  Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study , 2006, Journal of Korean medical science.

[34]  J. Weiss,et al.  Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. , 2006, Urology.

[35]  T. Tammela,et al.  Is nocturia equally common among men and women? A population based study in Finland. , 2006, The Journal of urology.

[36]  R. Asplund,et al.  Nocturia and depression , 2004, BJU international.

[37]  J. Susset,et al.  Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. , 2004, The Journal of urology.

[38]  N. Kinukawa,et al.  Prevalence of and risk factors for nocturia: Analysis of a health screening program , 2004, International journal of urology : official journal of the Japanese Urological Association.

[39]  M. Drake,et al.  Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. , 2004, The Journal of urology.

[40]  M. Wyllie,et al.  Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies , 2003, BJU international.

[41]  M. Kutner,et al.  Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. , 2003, The Journal of urology.

[42]  S. Ayers,et al.  Outcomes after total versus subtotal abdominal hysterectomy. , 2002, The New England journal of medicine.

[43]  Poul Jennum,et al.  The standardisation of terminology in nocturia: Report from the standardisation sub‐committee of the International Continence Society , 2002, Neurourology and urodynamics.

[44]  T. Wilt,et al.  Pygeum africanum for benign prostatic hyperplasia. , 1998, The Cochrane database of systematic reviews.

[45]  E. Frohman,et al.  Bladder, bowel, and sexual dysfunction in multiple sclerosis , 2001, Current treatment options in neurology.

[46]  T. Wilt,et al.  Cernilton for benign prostatic hyperplasia. , 2011, The Cochrane database of systematic reviews.

[47]  G. Lose,et al.  Risk Factors for Lower Urinary Tract Symptoms in Women 40 to 60 Years of Age , 2000, Obstetrics and gynecology.

[48]  T. Wilt,et al.  Serenoa repens for benign prostatic hyperplasia. , 2000, The Cochrane database of systematic reviews.

[49]  P. Abrams,et al.  A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. , 1998, British journal of urology.

[50]  M. Marberger,et al.  The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives. , 1997, The Journal of urology.

[51]  A. Okada,et al.  Triazolam and Nitrazepam Use in Elderly Outpatients , 1993, The Annals of pharmacotherapy.

[52]  P. Johansen,et al.  Prophylactic treatment of adult nocturia with bumetanide. , 1988, British journal of urology.